Monday, November 17, 2014

#Actavis is now in the final stages of a buyout of #Allergan the #Botox maker for about $64 billion to stop a hostile takeover from #Valeant

Actavis is now in the final stages of a buyout of Allergan the Botox maker for about $64 billion to stop a hostile takeover from Valeant
http://www.wikio.co.uk